Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

Chronic biofilm‐associated infections caused by Staphylococcus aureus often lead to
significant increases in morbidity and mortality, particularly when associated with indwelling …

The contribution of biofilms to virulence and as a barrier to treatment is well-established for
Staphylococcus aureus and Enterococcus faecalis, both nosocomial pathogens frequently …

Staphylococcus aureus (S. aureus) causes persistent biofilm-related infections. Biofilm
formation by S. aureus is affected by the culture conditions and is associated with certain …

The need for bone and joint prostheses is currently growing due to population aging,
leading to an increase in prosthetic joint infection cases. Biofilms represent an adaptive and …

It has been demonstrated that some non-steroidal anti-inflammatory drugs (NSAIDs), like
acetylsalicylic acid, diclofenac, and ibuprofen, have anti-biofilm activity in concentrations …

Methicillin-resistant Staphylococcus aureus (MRSA) is a drug-resistant superbug that
causes various types of community-and hospital-acquired infectious diseases. The current …

The early colonization of surfaces and subsequent biofilm development have severe
impacts in environmental, industrial, and biomedical settings since they entail high costs and …

Bacteriocins are ribosomally-synthesized antimicrobial peptides, showing great potential as
novel treatment options for multidrug-resistant pathogens. In this study, we designed a novel …

The objective of this study was to compare the biofilm-forming capabilities of different
genotypes of Staphylococcus aureus dairy isolates from Switzerland and northern Italy …